<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To explore the expression of insulin-like growth factor receptor type I (IGF-IR) and its relationship to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in hematopoietic cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow, bone marrow nucleated cells from 16 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and 16 patients with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) were collected for analysis, respectively </plain></SENT>
<SENT sid="1" pm="."><plain>Another 16 <z:mpath ids='MPATH_458'>normal</z:mpath> donors' marrow samples were taken as controls </plain></SENT>
<SENT sid="2" pm="."><plain>Immunocytochemical method (APAAP) and TdT-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling (TUNEL) fluorescence were used simultaneously on cytospins of nucleated cells from these patients </plain></SENT>
<SENT sid="3" pm="."><plain>Then, the ratios of IGF-IR positive cells and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> cells in <z:hpo ids='HP_0000001'>all</z:hpo> nucleated cells were counted separately </plain></SENT>
<SENT sid="4" pm="."><plain>The results showed that (1) there was a higher IGF-IR expression rate (56.8 +/- 14.3)% in nucleated cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow than that in <z:mpath ids='MPATH_458'>normal</z:mpath> marrow (40.4 +/- 9.6)% (P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>Also IGF-IR positive rate in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow (86.8 +/- 13.8)% was significantly higher than that in <z:mpath ids='MPATH_458'>normal</z:mpath> marrow (P &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, IGF-IR had higher expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow when compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow (P &lt; 0.01); (2) <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in nucleated cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow (5.4 +/- 3.0)% was significantly higher than that in <z:mpath ids='MPATH_458'>normal</z:mpath> marrow (1.2 +/- 0.9)% (P &lt; 0.01) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow (0.3 +/- 0.4)% (P &lt; 0.01), while there was less <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow than that in <z:mpath ids='MPATH_458'>normal</z:mpath> marrow (P &lt; 0.01); (3) <z:mpath ids='MPATH_3'>apoptosis</z:mpath> occurred mainly in IGF-IR negative cells (9.0 +/- 4.8)% and less in IGF-IR positive cells (1.4 +/- 2.4)% (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>IGF-IR expression showed negative correlation with <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (r = -0.852, P &lt; 0.01); (4) IGF-IR of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> nucleated cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> expressed higher than that in RA/<z:mp ids='MP_0011356'>RAS</z:mp> (64.1 +/- 3.2% vs 53.5 +/- 16.2%) subgroup, although no significant difference was found (P &gt; 0.05); and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> subgroup was lower than that in RA/<z:mp ids='MP_0011356'>RAS</z:mp> cases (3.1 +/- 2.1% vs 6.4 +/- 2.8%) (P &lt; 0.05); (5) IGF-IR positive rate in nucleated cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow showed positive correlation with blast rate (r = 0.677; P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>It is concluded that there is overexpression of IGF-IR in marrow nucleated cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cases </plain></SENT>
<SENT sid="9" pm="."><plain>And it seems that the overexpression of IGF-IR may suggest some malignant proliferation tendency and suppress cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through some mechanism in these malignant hematologic ailments </plain></SENT>
<SENT sid="10" pm="."><plain>So, anti-IGF-IR will become a new approach for therapy of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
</text></document>